Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages
1Department of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA; Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.
Related Experiment Videos
View abstract on PubMed
Summary
Researchers developed a fast method to create vascular organoids (VOs) from stem cells. This breakthrough allows better control over blood vessel development for disease study and regenerative medicine.
Area of Science:
- Stem cell biology
- Vascular biology
- Regenerative medicine
Background:
- Vascular organoids (VOs) are crucial for studying vascular development and disease.
- Independent control of endothelial and mural cells in VOs is a significant challenge.
Purpose of the Study:
- To develop a streamlined method for generating functional vascular organoids (VOs) from induced pluripotent stem cells (iPSCs).
- To enable independent control over endothelial and mural cell differentiation within VOs.
- To establish a versatile platform for vascular modeling and regenerative therapy.
Main Methods:
- Utilized orthogonal activation of transcription factors ETV2 and NKX3.1 via Dox-inducible or modRNA systems.
- Generated 3D VOs from iPSCs within 5 days without extracellular matrix (ECM) embedding.
- Analyzed VO development using single-cell RNA sequencing and in vivo engraftment studies.
Main Results:
- Successfully generated functional 3D VOs with co-differentiated endothelial cells (iECs) and mural cells (iMCs).
- Demonstrated temporal regulation of TF expression modulated iEC phenotypes (arterial, angiogenic).
- Showcased in vivo functionality: VOs engrafted, formed perfused vasculature, and promoted revascularization in disease models.
Conclusions:
- Established a rapid and versatile vascular organoid platform.
- The method allows for precise control over vascular cell types and phenotypes.
- VOs show significant potential for vascular disease modeling and cell-based regenerative therapies.